- 질문내용 -
Hold the line, please cheap xplozion Winald Gerritsen of the Radboud University Nijmegen Medical Centre in the Netherlands, noted that although the study did not meet its primary endpoint, there is “a suggestion of greater activity in those with less advanced CRPC”. He claimed that “these results offer important insights for ongoing and future studies of Yervoy in prostate cancer”, including an ongoing second large trial in patients with less advanced disease.
|
|
